Opinion|Videos|November 9, 2023

Methods for Continuous IRP Monitoring in Patients With Urinary Stones

Author(s)Michelle Semins, MD, Seth Bechis, MD

Experts converse on the evolving methods for real-time intra-renal pressure monitoring, its benefits in improving surgical procedures, and the potential for future automated adjustments based on the monitored data.

Episodes in this series

EP. 1 Overview of the Incidence, Diagnosis, and Treatment of Urinary Stones

EP. 1 Overview of the Incidence, Diagnosis, and Treatment of Urinary Stones

EP. 2 The Evolving Role of Ureteroscopy in the Treatment of Urinary Stones

EP. 2 The Evolving Role of Ureteroscopy in the Treatment of Urinary Stones

EP. 3 Overview of Intrarenal Pressure (IRP)

EP. 3 Overview of Intrarenal Pressure (IRP)

EP. 4 Potential Complications Seen in Patients With Elevated IRP

EP. 4 Potential Complications Seen in Patients With Elevated IRP

EP. 5 Strategies for Reducing Risk of Elevated IRP

EP. 5 Strategies for Reducing Risk of Elevated IRP

EP. 6 Key Treatment and Outcome Data for Patients Undergoing Therapy with Assistance of Ureteral Access Sheaths (UASs)

EP. 6 Key Treatment and Outcome Data for Patients Undergoing Therapy with Assistance of Ureteral Access Sheaths (UASs)

EP. 7 Factors for Consideration When Employing UASs In Patients With Urinary Stones

EP. 7 Factors for Consideration When Employing UASs In Patients With Urinary Stones

EP. 8 Methods for Continuous IRP Monitoring in Patients With Urinary Stones

EP. 8 Methods for Continuous IRP Monitoring in Patients With Urinary Stones

EP. 9 Future Perspectives in the Treatment of Patients With Urinary Stones

EP. 9 Future Perspectives in the Treatment of Patients With Urinary Stones

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

Residual stone volume outperforms stone-free rate as risk marker

ByBrett Johnson, MD

July 17th 2026

Amy E. Krambeck, MD, on choosing between CVAC and FANS for suction-based ureteroscopy

ByAmy E. Krambeck, MD

July 10th 2026

Study links unmet social needs with worse stone-specific quality of life

ByMichael John Mari Talagsa Uy, MD

July 6th 2026

From OR to office: How Break Wave changes urology practice workflow

ByBen H. Chew, MD, MSc

July 3rd 2026

Economic analysis: SURE reduces downstream stone costs

ByBrett Johnson, MD

July 1st 2026

Latest CME

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Radioligand Therapy 101: The Science Behind the Strategy

Radioligand Therapy 101: The Science Behind the Strategy

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Ana Kiess, MD, PhD; Erin Grady, MD, CCD, FACNM, FSNMMI; Himanshu Nagar, MD, MS; Scott T. Tagawa, MD, MS, FASCO, FACP

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Trending on Urology Times

CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom

The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD

Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy

FDA grants breakthrough therapy, fast track designations to kidney cancer imaging agent

Kari Tikkinen, MD, PhD, discusses POISE-3 findings on tranexamic acid in urologic surgery